Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Azole resistance in Aspergillus fumigatus isolates from the ARTEMIS global surveillance study is primarily due to the TR/L98H mutation in the cyp51A gene.

Lockhart SR, Frade JP, Etienne KA, Pfaller MA, Diekema DJ, Balajee SA.

Antimicrob Agents Chemother. 2011 Sep;55(9):4465-8. doi: 10.1128/AAC.00185-11.

2.

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India.

Chowdhary A, Kathuria S, Randhawa HS, Gaur SN, Klaassen CH, Meis JF.

J Antimicrob Chemother. 2012 Feb;67(2):362-6. doi: 10.1093/jac/dkr443.

PMID:
22028200
3.

cyp51A-Based mechanisms of Aspergillus fumigatus azole drug resistance present in clinical samples from Germany.

Bader O, Weig M, Reichard U, Lugert R, Kuhns M, Christner M, Held J, Peter S, Schumacher U, Buchheidt D, Tintelnot K, Groß U; MykoLabNet-D Partners..

Antimicrob Agents Chemother. 2013 Aug;57(8):3513-7. doi: 10.1128/AAC.00167-13.

4.

First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.

Özmerdiven GE, Ak S, Ener B, Ağca H, Cilo BD, Tunca B, Akalın H.

J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012.

PMID:
26048062
5.

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms.

Arendrup MC, Jensen RH, Cuenca-Estrella M.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):532-6. doi: 10.1128/AAC.02336-15.

6.

Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.

Mohammadi F, Hashemi SJ, Zoll J, Melchers WJ, Rafati H, Dehghan P, Rezaie S, Tolooe A, Tamadon Y, van der Lee HA, Verweij PE, Seyedmousavi S.

Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15.

7.

Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.

Chowdhary A, Kathuria S, Xu J, Sharma C, Sundar G, Singh PK, Gaur SN, Hagen F, Klaassen CH, Meis JF.

PLoS One. 2012;7(12):e52871. doi: 10.1371/journal.pone.0052871.

8.

Azole, polyene and echinocandin MIC distributions for wild-type, TR34/L98H and TR46/Y121F/T289A Aspergillus fumigatus isolates in the Netherlands.

van Ingen J, van der Lee HA, Rijs TA, Zoll J, Leenstra T, Melchers WJ, Verweij PE.

J Antimicrob Chemother. 2015 Jan;70(1):178-81. doi: 10.1093/jac/dku364.

PMID:
25301884
9.

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis.

Morio F, Aubin GG, Danner-Boucher I, Haloun A, Sacchetto E, Garcia-Hermoso D, Bretagne S, Miegeville M, Le Pape P.

J Antimicrob Chemother. 2012 Aug;67(8):1870-3. doi: 10.1093/jac/dks160.

PMID:
22581906
10.

Azole resistance profile of amino acid changes in Aspergillus fumigatus CYP51A based on protein homology modeling.

Snelders E, Karawajczyk A, Schaftenaar G, Verweij PE, Melchers WJ.

Antimicrob Agents Chemother. 2010 Jun;54(6):2425-30. doi: 10.1128/AAC.01599-09.

11.

Aspergillus fumigatus strains with mutations in the cyp51A gene do not always show phenotypic resistance to itraconazole, voriconazole, or posaconazole.

Escribano P, Recio S, Peláez T, Bouza E, Guinea J.

Antimicrob Agents Chemother. 2011 May;55(5):2460-2. doi: 10.1128/AAC.01358-10.

12.

Aspergillus species and other molds in respiratory samples from patients with cystic fibrosis: a laboratory-based study with focus on Aspergillus fumigatus azole resistance.

Mortensen KL, Jensen RH, Johansen HK, Skov M, Pressler T, Howard SJ, Leatherbarrow H, Mellado E, Arendrup MC.

J Clin Microbiol. 2011 Jun;49(6):2243-51. doi: 10.1128/JCM.00213-11.

13.
14.

Azole preexposure affects the Aspergillus fumigatus population in patients.

Alanio A, Cabaret O, Sitterlé E, Costa JM, Brisse S, Cordonnier C, Bretagne S.

Antimicrob Agents Chemother. 2012 Sep;56(9):4948-50. doi: 10.1128/AAC.05990-11.

15.

Multiple cyp51A-based mechanisms identified in azole-resistant isolates of Aspergillus fumigatus from China.

Liu M, Zeng R, Zhang L, Li D, Lv G, Shen Y, Zheng H, Zhang Q, Zhao J, Zheng N, Liu W.

Antimicrob Agents Chemother. 2015 Jul;59(7):4321-5. doi: 10.1128/AAC.00003-15.

16.

Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran.

Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, Ansari S, Hagen F, Meis JF, Chowdhary A.

Mycoses. 2013 Nov;56(6):659-63. doi: 10.1111/myc.12089.

PMID:
23668594
17.

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.

Alanio A, Sitterlé E, Liance M, Farrugia C, Foulet F, Botterel F, Hicheri Y, Cordonnier C, Costa JM, Bretagne S.

J Antimicrob Chemother. 2011 Feb;66(2):371-4. doi: 10.1093/jac/dkq450.

PMID:
21131690
18.

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.

Bueid A, Howard SJ, Moore CB, Richardson MD, Harrison E, Bowyer P, Denning DW.

J Antimicrob Chemother. 2010 Oct;65(10):2116-8. doi: 10.1093/jac/dkq279.

PMID:
20729241
20.

Occurrence of triazole-resistant Aspergillus fumigatus with TR34/L98H mutations in outdoor and hospital environment in Kuwait.

Ahmad S, Khan Z, Hagen F, Meis JF.

Environ Res. 2014 Aug;133:20-6. doi: 10.1016/j.envres.2014.05.009.

PMID:
24906064

Supplemental Content

Support Center